| Application no. and date | 17728484.1 (espacenet) (Federated) (European Patent Register), 20170530 | | Patent/reg. no. and date | DK/EP 3465214, 20210428 | | Publication date | 20190410 | | Priority no. and date | EP 16171885, 20160530 | | EP pub. no. and date |
EP 3465214 20190410 | | Effective date | | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington
Delaware 19803
, US | | Applicant ref. no. | P76367DK01 | | Inventor | ENDELL, Jan, Barer Str. 36
80333 München, DE,
WINDERLICH, Mark, Ohlstadterstr. 8
81373 München, DE,
BOXHAMMER, Rainer, Birkenstraße 4a
83059 Kolbermoor, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | G01N 33/574 (2006.01) | | Title | FREMGANGSMÅDER TIL FORUDSIGELSE AF TERAPEUTISK FORDEL VED ANTI-CD19-TERAPI HOS PATIENTER | | Int. application no. | EP2017063045 | | Int. publication no. | WO2017207574 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
